Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Post by fundtraderon Oct 15, 2016 2:40pm
73 Views
Post# 25347237

60 new products..

60 new products..
lets say each drug has an annual revenue of 5 million thats 300 million in annual revenue every year. That would not only replace any loss but would actually put this company in growth. In addition they could easily acquire another additional 200 million in revenue by spending 50 to 75 million by buying companies out there.
<< Previous
Bullboard Posts
Next >>